Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: MarketLine (a Datamonitor Company)
$50.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Okmetic still expects net sales and operating profit to grow in FY 2014


Thursday, 24 Apr 2014 01:00am EDT 

Okmetic Oyj:Still expects FY 2014 net sales and operating profit to exceed the level of year 2013.Reported net sales of 68.5 million euros and operating profit of 5 million euros in FY 2013.FY 2014 revenue 74.21 million euros, EBIT 6.86 million - Thomson Reuters I/B/E/S Estimates. 

Company Quote

7.12
 --
22 May 2015